Rengifo E - Search Results

1

Histochemical and ultrastructural study of human colon preneoplastic stages.

Rodríguez T, Tormo B, Rengifo E, Grá B, González N, Mandado S. Rodríguez T, et al. Among authors: rengifo e. Arch Geschwulstforsch. 1987;57(4):287-96. Arch Geschwulstforsch. 1987. PMID: 3675141

2

Ultrastructural study of glycogen containing cells in colonic adenocarcinomas and precancerous polypoid lesions.

Tormo B, Rodríguez T, Rengifo E, Mandado S, González N, Gra B. Tormo B, et al. Among authors: rengifo e. Arch Geschwulstforsch. 1987;57(1):39-46. Arch Geschwulstforsch. 1987. PMID: 3566464

3

Morphologic and cytochemical study of L929 cell variants with different metastasizing ability in C3HA/Hab mice.

Rodríguez T, Rengifo E, Gavilondo J, Tormo B, Fernández A. Rodríguez T, et al. Among authors: rengifo e. Neoplasma. 1984;31(3):271-9. Neoplasma. 1984. PMID: 6377099

4

Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target.

Blanco R, Cedeño M, González N, Rodríguez R, Sánchez J, Rengifo E. Blanco R, et al. Among authors: rengifo e. Acta Pharm. 2012 Dec;62(4):581-91. doi: 10.2478/v10007-012-0038-6. Acta Pharm. 2012. PMID: 23333890 Free article.

5

Burkitt's lymphoma in Cuba. I. Clinical and morphological features and EBV association.

Riverend E, Rengifo E, Longchong M, Ruíz R, Tormo B, Garćia J, Portero R, Quintero S, Valdés M, Rodríguez T, et al. Riverend E, et al. Among authors: rengifo e. Oncology. 1984;41(1):13-8. doi: 10.1159/000225783. Oncology. 1984. PMID: 6322085

6

Clinical features of Hodgkin's disease in Cuba and Sweden.

Rengifo E, Merk K, Björkholm M, Holm G, Johansson B, Rivas H, Marinello Z. Rengifo E, et al. Neoplasma. 1989;36(6):719-28. Neoplasma. 1989. PMID: 2615875

7

Immunohistochemical recognition of the epidermal growth factor receptor by the h-R3 antibody in the skin of experimental animals.

Maceira M, Rengifo E, Cedeño M, Merino N, Casacó Parada A. Maceira M, et al. Among authors: rengifo e. Appl Immunohistochem Mol Morphol. 2004 Dec;12(4):360-3. doi: 10.1097/00129039-200412000-00013. Appl Immunohistochem Mol Morphol. 2004. PMID: 15536338

8

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.

Blanco R, Rengifo CE, Cedeño M, Frómeta M, Rengifo E, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. Patholog Res Int. 2012;2012:235418. doi: 10.1155/2012/235418. Epub 2012 Feb 26. Patholog Res Int. 2012. PMID: 22482082 Free PMC article.

9

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.

Blanco R, Rengifo E, Cedeño M, Rengifo CE, Alonso DF, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. ISRN Gastroenterol. 2011;2011:645641. doi: 10.5402/2011/645641. Epub 2010 Dec 2. ISRN Gastroenterol. 2011. PMID: 21991524 Free PMC article.

10

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.

Blanco R, Rengifo E, Rengifo CE, Cedeño M, Frómeta M, Carr A. Blanco R, et al. Among authors: rengifo e, rengifo ce. ISRN Dermatol. 2011;2011:848909. doi: 10.5402/2011/848909. Epub 2011 Apr 10. ISRN Dermatol. 2011. PMID: 22363862 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters